Prevalence of antidepressants and biosimilars in elite sport - a follow-up study

Research output: Chapter in Book/Report/Conference proceedingConference contribution - Article for conferenceResearch

Standard

Prevalence of antidepressants and biosimilars in elite sport - a follow-up study. / Reinartz, Anja; Sigmund, Gerd; Machnik, Marc; Thevis, Mario; Schänzer, Wilhelm.

Recent advances in doping analysis (20) : Proceedings of the Manfred-Donike-Workshop, 30th Cologne Workshop on Dope Analysis : 26th February to 2nd March 2012 2. Variante. ed. / Wilhelm Schänzer; Mario Thevis; Hans Geyer; Ute Mareck. Sportverlag Strauß, 2012. p. 246-249 (Recent advances in doping analysis; Vol. 20).

Research output: Chapter in Book/Report/Conference proceedingConference contribution - Article for conferenceResearch

Harvard

Reinartz, A, Sigmund, G, Machnik, M, Thevis, M & Schänzer, W 2012, Prevalence of antidepressants and biosimilars in elite sport - a follow-up study. in W Schänzer, M Thevis, H Geyer & U Mareck (eds), Recent advances in doping analysis (20) : Proceedings of the Manfred-Donike-Workshop, 30th Cologne Workshop on Dope Analysis : 26th February to 2nd March 2012 2. Variante. Recent advances in doping analysis, vol. 20, Sportverlag Strauß, pp. 246-249, Cologne Workshop on Dope Analysis, Köln, Germany, 26.02.12.

APA

Reinartz, A., Sigmund, G., Machnik, M., Thevis, M., & Schänzer, W. (2012). Prevalence of antidepressants and biosimilars in elite sport - a follow-up study. In W. Schänzer, M. Thevis, H. Geyer, & U. Mareck (Eds.), Recent advances in doping analysis (20) : Proceedings of the Manfred-Donike-Workshop, 30th Cologne Workshop on Dope Analysis : 26th February to 2nd March 2012 2. Variante (pp. 246-249). (Recent advances in doping analysis; Vol. 20). Sportverlag Strauß.

Vancouver

Reinartz A, Sigmund G, Machnik M, Thevis M, Schänzer W. Prevalence of antidepressants and biosimilars in elite sport - a follow-up study. In Schänzer W, Thevis M, Geyer H, Mareck U, editors, Recent advances in doping analysis (20) : Proceedings of the Manfred-Donike-Workshop, 30th Cologne Workshop on Dope Analysis : 26th February to 2nd March 2012 2. Variante. Sportverlag Strauß. 2012. p. 246-249. (Recent advances in doping analysis).

Bibtex

@inbook{9a2ba291628b4fd892bedac12fb821ae,
title = "Prevalence of antidepressants and biosimilars in elite sport - a follow-up study",
abstract = "Antidepressants are not prohibited by the World Anti-Doping Agency for the use in elite sports since the deregulation of amineptine in 2003. A study by Machnik et al. indicated a rise in antidepressant usage by athletes. Based on this survey a follow-up research was initiated to investigate the onward usage of these substances in relation to the general population. From 1999 to 2011 approximately 116.000 doping control samples from 236 sporting different disciplines were analysed for the presence of antidepressants with an analytical-chemistry-based screening procedure routinely used by WADA-accredited laboratories by means of gas chromatography-mass spectrometry. Assessing the results for elite sport, prescription data for the general population were consulted provided by the German statutory health insurance. The prevalence of antidepressants in elite sports (0.35%) was well below the medication in the general population (2.25%). The results revealed a steady rise from 1999 to 2006, an abrupt increase in 2007 and 2008 followed by a decrease in 2009 to 2011 to the level of 2007. Most of the detected substances belonged to the class of selective serotonin reuptake inhibitors. The dimension of depressive disorders in elite sports remains vague according to the study design. There is no indication for an application of antidepressants as neuroenhancement by athletes to a greater extent. Verf.-Referat",
keywords = "Biochemie, Doping, Dopinganalyse, Dopingnachweis, Gaschromatographie, Hochleistungssport, Massenspektrometrie, Psychopharmakon, Screening, Urin, Urinausscheidung, Urinuntersuchung",
author = "Anja Reinartz and Gerd Sigmund and Marc Machnik and Mario Thevis and Wilhelm Sch{\"a}nzer",
year = "2012",
language = "Deutsch",
series = "Recent advances in doping analysis",
publisher = "Sportverlag Strau{\ss}",
pages = "246--249",
editor = "Wilhelm Sch{\"a}nzer and Mario Thevis and Hans Geyer and Ute Mareck",
booktitle = "Recent advances in doping analysis (20) : Proceedings of the Manfred-Donike-Workshop, 30th Cologne Workshop on Dope Analysis : 26th February to 2nd March 2012 2. Variante",
note = "Cologne Workshop on Dope Analysis ; Conference date: 26-02-2012 Through 02-03-2012",

}

RIS

TY - CHAP

T1 - Prevalence of antidepressants and biosimilars in elite sport - a follow-up study

AU - Reinartz, Anja

AU - Sigmund, Gerd

AU - Machnik, Marc

AU - Thevis, Mario

AU - Schänzer, Wilhelm

N1 - Conference code: 30

PY - 2012

Y1 - 2012

N2 - Antidepressants are not prohibited by the World Anti-Doping Agency for the use in elite sports since the deregulation of amineptine in 2003. A study by Machnik et al. indicated a rise in antidepressant usage by athletes. Based on this survey a follow-up research was initiated to investigate the onward usage of these substances in relation to the general population. From 1999 to 2011 approximately 116.000 doping control samples from 236 sporting different disciplines were analysed for the presence of antidepressants with an analytical-chemistry-based screening procedure routinely used by WADA-accredited laboratories by means of gas chromatography-mass spectrometry. Assessing the results for elite sport, prescription data for the general population were consulted provided by the German statutory health insurance. The prevalence of antidepressants in elite sports (0.35%) was well below the medication in the general population (2.25%). The results revealed a steady rise from 1999 to 2006, an abrupt increase in 2007 and 2008 followed by a decrease in 2009 to 2011 to the level of 2007. Most of the detected substances belonged to the class of selective serotonin reuptake inhibitors. The dimension of depressive disorders in elite sports remains vague according to the study design. There is no indication for an application of antidepressants as neuroenhancement by athletes to a greater extent. Verf.-Referat

AB - Antidepressants are not prohibited by the World Anti-Doping Agency for the use in elite sports since the deregulation of amineptine in 2003. A study by Machnik et al. indicated a rise in antidepressant usage by athletes. Based on this survey a follow-up research was initiated to investigate the onward usage of these substances in relation to the general population. From 1999 to 2011 approximately 116.000 doping control samples from 236 sporting different disciplines were analysed for the presence of antidepressants with an analytical-chemistry-based screening procedure routinely used by WADA-accredited laboratories by means of gas chromatography-mass spectrometry. Assessing the results for elite sport, prescription data for the general population were consulted provided by the German statutory health insurance. The prevalence of antidepressants in elite sports (0.35%) was well below the medication in the general population (2.25%). The results revealed a steady rise from 1999 to 2006, an abrupt increase in 2007 and 2008 followed by a decrease in 2009 to 2011 to the level of 2007. Most of the detected substances belonged to the class of selective serotonin reuptake inhibitors. The dimension of depressive disorders in elite sports remains vague according to the study design. There is no indication for an application of antidepressants as neuroenhancement by athletes to a greater extent. Verf.-Referat

KW - Biochemie

KW - Doping

KW - Dopinganalyse

KW - Dopingnachweis

KW - Gaschromatographie

KW - Hochleistungssport

KW - Massenspektrometrie

KW - Psychopharmakon

KW - Screening

KW - Urin

KW - Urinausscheidung

KW - Urinuntersuchung

M3 - Konferenzbeitrag - Aufsatz in Konferenzband

T3 - Recent advances in doping analysis

SP - 246

EP - 249

BT - Recent advances in doping analysis (20) : Proceedings of the Manfred-Donike-Workshop, 30th Cologne Workshop on Dope Analysis : 26th February to 2nd March 2012 2. Variante

A2 - Schänzer, Wilhelm

A2 - Thevis, Mario

A2 - Geyer, Hans

A2 - Mareck, Ute

PB - Sportverlag Strauß

T2 - Cologne Workshop on Dope Analysis

Y2 - 26 February 2012 through 2 March 2012

ER -

ID: 186235